ARCHIVES

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

The Education Of Dan Flood Gets $60 Million Increase For NCI; House Votes HEW Money Bill

July 5, 1974

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

Research Base Would Be Increased In Guideline Change

November 9, 1990

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991